HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vitamin D Protects Against Atherosclerosis via Regulation of Cholesterol Efflux and Macrophage Polarization in Hypercholesterolemic Swine.

AbstractOBJECTIVE:
Prevalence of vitamin D (VD) deficiency and its association with the risk of cardiovascular disease prompted us to evaluate the effect of VD status on lipid metabolism and atherosclerosis in hypercholesterolemic microswine.
APPROACH AND RESULTS:
Yucatan microswine were fed with VD-deficient (0 IU/d), VD-sufficient (1000 IU/d), or VD-supplemented (3000 IU/d) high-cholesterol diet for 48 weeks. Serum lipids and 25(OH)-cholecalciferol levels were measured biweekly. Histology and biochemical parameters of liver and arteries were analyzed. Effect of 1,25(OH)2D3 on cholesterol metabolism was examined in human hepatocyte carcinoma cell line (HepG2) and human monocytic cell line (THP-1) macrophage-derived foam cells. VD deficiency decreased plasma high-density lipoprotein levels, expression of liver X receptors, ATP-binding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 and promoted cholesterol accumulation and atherosclerosis in hypercholesterolemic microswine. VD promoted nascent high-density lipoprotein formation in HepG2 cells via ATP-binding membrane cassette transporter A1-mediated cholesterol efflux. Cytochrome P450 (CYP)27B1 and VD receptor were predominantly present in the CD206(+) M2 macrophage foam cell-accumulated cores in coronary artery plaques. 1,25(OH)2D3 increased the expression of liver X receptors, ATP-binding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 and promoted cholesterol efflux in THP-1 macrophage-derived foam cells. 1,25(OH)2D3 decreased intracellular free cholesterol and polarized macrophages to M2 phenotype with decreased expression of tumor necrosis factor-α, interleukin-1β, interleukin-6 under lipopolysaccharide stimulation. 1,25(OH)2D3 markedly induced CYP27A1 expression via a VD receptor-dependent c-Jun N-terminal kinase (JNK) 1/2 signaling pathway and increased 27-hydroxycholesterol levels, which induced liver X receptors, ATP-binding membrane cassette transporter A1, and ATP-binding membrane cassette transporter G1 expression and stimulated cholesterol efflux that was inhibited by VD receptor antagonist and JNK1/2 signaling inhibitor in THP-1 macrophage-derived foam cell.
CONCLUSIONS:
VD protects against atherosclerosis in hypercholesterolemic swine via controlling cholesterol efflux and macrophage polarization via increased CYP27A1 activation.
AuthorsKai Yin, Yong You, Vicki Swier, Lin Tang, Mohamed M Radwan, Amit N Pandya, Devendra K Agrawal
JournalArteriosclerosis, thrombosis, and vascular biology (Arterioscler Thromb Vasc Biol) Vol. 35 Issue 11 Pg. 2432-42 (Nov 2015) ISSN: 1524-4636 [Electronic] United States
PMID26381871 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Copyright© 2015 The Authors.
Chemical References
  • ABCA1 protein, human
  • ABCG1 protein, human
  • ATP Binding Cassette Transporter 1
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters
  • Biomarkers
  • Cholesterol, HDL
  • Hydroxycholesterols
  • Liver X Receptors
  • Orphan Nuclear Receptors
  • Receptors, Calcitriol
  • VDR protein, human
  • 27-hydroxycholesterol
  • Cholesterol
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase
  • JNK Mitogen-Activated Protein Kinases
  • Calcitriol
  • Calcifediol
Topics
  • 25-Hydroxyvitamin D3 1-alpha-Hydroxylase (metabolism)
  • ATP Binding Cassette Transporter 1 (metabolism)
  • ATP Binding Cassette Transporter, Subfamily G, Member 1
  • ATP-Binding Cassette Transporters (metabolism)
  • Animals
  • Atherosclerosis (blood, diagnosis, etiology, prevention & control)
  • Biomarkers (blood)
  • Calcifediol (blood)
  • Calcitriol (pharmacology)
  • Cholesterol (metabolism)
  • Cholesterol, HDL (blood)
  • Disease Models, Animal
  • Hep G2 Cells
  • Hepatocytes (drug effects, metabolism)
  • Humans
  • Hydroxycholesterols (metabolism)
  • Hypercholesterolemia (blood, complications, diagnosis, drug therapy)
  • JNK Mitogen-Activated Protein Kinases (metabolism)
  • Liver X Receptors
  • Macrophages (drug effects, metabolism)
  • Orphan Nuclear Receptors (metabolism)
  • Phenotype
  • Receptors, Calcitriol (agonists, metabolism)
  • Swine
  • Swine, Miniature
  • Time Factors
  • Vitamin D Deficiency (blood, complications, diagnosis, drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: